Institutes, Centers and Laboratories

The Child & Maternal Health Research Institute is comprised of many institutes, centers and laboratories that work collaboratively towards a common goal. 

Front of the Jacobs School of Medicine and Biomedical Sciences building.

Affiliated Institutes

The Institute for Autism Research (IAR) is an interdisciplinary collaborative research center, co-directed by Dr Christopher Lopata and Dr Marcus Thomeer, dedicated to understanding autism and enhancing the lives of autistic children and their families. Researchers from diverse backgrounds work together to address critical questions involving causes, development, assessment, interventions, and education. This research work has led to development of several new and effective programs for autistic children without intellectual disabilities (ID) that include summerMAX, MAXout, and schoolMAX

Research Centers

Center for Ingestive Behavior Research (CIBR)

The UB Center for Ingestive Behavior Research is the administrative hub for the University at Buffalo Ingestive Behavior (UBIB) community. They provide research resources and administration for members of the Center and connect faculty members who have complementary research interests.

Individual Laboratories

The Child Health and Behavior Lab (HABLAB)

The Child Health and Behavior Lab (HABLAB) is a research laboratory within the Division of Behavioral Medicine run by Dr Stephanie Anzman-Frasca. They conduct studies on various aspects of young children's health and behavior in the laboratory and community. 

Dr Hicar's Laboratory

The Hicar lab focuses on discovering and characterizing human antibodies against infectious diseases, including influenza and HIV, using advanced single-cell and genomic techniques to inform vaccine development and identify functional immune targets. Current work extends these approaches to uncover infectious triggers of inflammatory conditions with as Kawasaki disease, MIS-C, and Alzheimer’s disease by identifying shared antibody responses and generating monoclonal antibodies from public clonotypes.